Centene Corp (STU:QEN)
€ 69.55 -1.97 (-2.75%) Market Cap: 36.83 Bil Enterprise Value: 35.29 Bil PE Ratio: 14.84 PB Ratio: 1.48 GF Score: 91/100

Centene Corp at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 12:00PM GMT
Release Date Price: €51.1 (+0.61%)
Steven J. James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

I'm Steven Valete, the health care services analyst. We're going to kick things off with Centene. To my left here is Michael Neidorff, company CEO. And also, Ed Kroll from Investor Relations is here as well.

This will be a fireside chat. We'll fire off some ARS audience questions maybe somewhere in the middle of this session. I know people would love to hear from Michael on his thoughts on policy, D.C.-related topics, et cetera, so we'll start there and drill down a little more into the company specifics. So first, welcome.

Michael Frederic Neidorff
Centene Corporation - Chairman & CEO

Thank you.

Questions & Answers

Steven J. James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great. So just to kick things off, progressive Democrats make the headlines on Medicare-for-All. I'm pretty sure most people have heard about that by now. But more moderate proposals such as public

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot